San Diego, California–(Newsfile Corp. – April 29, 2021) – Tryp Therapeutics Inc. (CSE: TRYP) (“ Tryp” or the “Company“), today announced its interim financial results for the three and six month periods ended February 28, 2021. Complete financial statements along with related management discussion and analysis can be found in the System for Electronic Document Analysis and Retrieval…


Previous articleBetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs
Next articleBexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation